Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance
- PMID: 17681492
- DOI: 10.1016/j.coph.2007.06.009
Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance
Abstract
The human glutathione S-transferase, GSTs, possess both enzymatic and non-enzymatic functions and are involved in many important cellular processes, such as, phase II metabolism, stress response, cell proliferation, apoptosis, oncogenesis, tumor progression and drug resistance. The non-enzymatic functions of GSTs involve their interactions with cellular proteins, such as, JNK, TRAF, ASK, PKC, and TGM2, during which, either the interacting protein partner undergoes functional alteration or the GST protein itself is post-translationally modified and/or functionally altered. The majority of GST genes harbor polymorphisms that influence their transcription and/or function of their encoded proteins. This overview focuses on recent insights into the biology and pharmacogenetics of GSTs as a determinant of cancer drug resistance and response of cancer patients to therapy.
Similar articles
-
The Multifaceted Role of Glutathione S-Transferases in Health and Disease.Biomolecules. 2023 Apr 18;13(4):688. doi: 10.3390/biom13040688. Biomolecules. 2023. PMID: 37189435 Free PMC article. Review.
-
The multifaceted role of glutathione S-transferases in cancer.Cancer Lett. 2018 Oct 1;433:33-42. doi: 10.1016/j.canlet.2018.06.028. Epub 2018 Jun 27. Cancer Lett. 2018. PMID: 29959055 Review.
-
Glutathione S - transferases class Pi and Mi and their significance in oncology.Postepy Hig Med Dosw (Online). 2017 Jun 19;71(0):541-550. doi: 10.5604/01.3001.0010.3835. Postepy Hig Med Dosw (Online). 2017. PMID: 28665283 Review.
-
Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.Cancer Chemother Pharmacol. 2015 Jan;75(1):1-15. doi: 10.1007/s00280-014-2566-x. Epub 2014 Aug 21. Cancer Chemother Pharmacol. 2015. PMID: 25143300 Review.
-
Glutathione S-transferases: an overview in cancer research.Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):153-70. doi: 10.1517/17425250903427980. Expert Opin Drug Metab Toxicol. 2010. PMID: 20078251 Review.
Cited by
-
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases.Antioxidants (Basel). 2023 Sep 29;12(10):1811. doi: 10.3390/antiox12101811. Antioxidants (Basel). 2023. PMID: 37891890 Free PMC article. Review.
-
The Upregulation of GSTO2 is Associated with Colon Cancer Progression and a Poor Prognosis.J Oncol. 2023 Jan 11;2023:4931650. doi: 10.1155/2023/4931650. eCollection 2023. J Oncol. 2023. PMID: 36688005 Free PMC article.
-
Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer.Medicina (Kaunas). 2022 Nov 16;58(11):1660. doi: 10.3390/medicina58111660. Medicina (Kaunas). 2022. PMID: 36422199 Free PMC article. Review.
-
Pharmacogenetics of Drugs Used in the Treatment of Cancers.Genes (Basel). 2022 Feb 7;13(2):311. doi: 10.3390/genes13020311. Genes (Basel). 2022. PMID: 35205356 Free PMC article. Review.
-
Short divalent ethacrynic amides as pro-inhibitors of glutathione S-transferase isozyme Mu and potent sensitisers of cisplatin-resistant ovarian cancers.J Enzyme Inhib Med Chem. 2022 Dec;37(1):728-742. doi: 10.1080/14756366.2022.2038591. J Enzyme Inhib Med Chem. 2022. PMID: 35176963 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous